Today, Roivant Sciences Ltd (NASDAQ: ROIV) Takes Center Stage

After Hours

The risks associated with pre-market and after-hours trading may be slightly higher than the regular market hours. The reason is that extended-hours trading may result in wider spreads for particular security due to lower liquidity and higher volatility as issuers often announce critical financial information outside regular trading hours.

3 Tiny Stocks Primed to Explode The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.

We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.

Click here for full details and to join for free

Stocks Info

The company is listed on the NASDAQ and operates within the Biotechnology industry segment. The current market capitalization of Roivant Sciences Ltd is $8.00B. A total of 4.66 million shares were traded on the day, compared to an average of 4.83M shares.

In the most recent transaction, Venker Eric sold 96,950 shares of ROIV for 10.92 per share on Feb 09 ’24. After the transaction, the President & COO now owns 532,207 company shares. In a previous transaction on Jan 02 ’24, Ramaswamy Vivek sold 3,000,000 shares at 11.05 per share. ROIV shares that 10% Owner owns now total 51,929,426.

Among the insiders who sold shares, Venker Eric disposed of 153,027 shares on Oct 05 ’23 at a per-share price of $10.11. This resulted in the Chief Operating Officer holding 595,397 shares of ROIV after the transaction. In another insider transaction, Venker Eric sold 606,221 shares at $10.25 per share on Oct 03 ’23. Company shares held by the Chief Operating Officer now total 595,397.

It has been observed that price targets are rarely accurate, but they can exert some influence from time to time, and are often accepted as valuable in the market. In terms of 52-week highs and lows, ROIV has a high of $13.24 and a low of $8.24.

Balance Sheet Annually/Quarterly

An equity investor’s investment can be viewed on a balance sheet by looking at what assets and liabilities the company has. Investors can determine the company’s prospects by calculating its financial ratios based on this information. ROIV’s latest balance sheet shows that the firm has $2.06B in Cash & Short Term Investments as of fiscal 2022. There were $283.89M in debt and $184.37M in liabilities at the time. Its Book Value Per Share was $7.40, while its Total Shareholder’s Equity was $2.06B.

Analysts Opinion

There may be slightly higher risks associated with pre-market and after-hours trading than during regular market hours. Due to the fact that issuers often announce critical financial information outside of regular trading hours, extended-hours trading may result in wider spreads for particular securities. Currently, 0 analysts are providing their opinions on the stock. On a scale of 1 to 5, with 1 being Sell and 5 being Buy, the average analyst rating for ROIV is Buy with a score of 4.82.

Most Popular

Related Posts